Pulmonologists are at the forefront of detecting and managing lung disease - and now, artificial intelligence (AI) is redefining what’s possible in early detection and workflow efficiency.

The Temple Lung Center has become the first pulmonary program in the nation to integrate AI into routine lung screening, using AI software as a core diagnostic tool that supports early detection, multidisciplinary review, and streamlined patient care pathways.

Through the Temple Healthy Chest Initiative’s dedicated lung screening program, every low-dose computed tomography (LDCT) scan is now processed using an AI-powered analytics platform designed to detect and flag abnormalities associated with lung nodules, COPD, coronary artery calcification, and early-stage lung cancer. By embedding this technology into a clinical workflow, Temple ensures that no scan goes under-reviewed and no subtle disease is overlooked.

Temple’s AI-driven model not only advances patient care, it redefines what's possible in preventive pulmonary medicine. By combining breakthrough precision technology with a collaborative multidisciplinary team, Temple is setting a new national standard for comprehensive, AI-supported screening and disease management.

Watch on Demand

The Temple Lung Center and CorelineSoft Present “LDCT+: A New Approach in Early Lung Disease Detection” to demonstrate how AI software elevates early detection and diagnostic outcomes in lung cancer screening.